Enliven Therapeutics, Inc.
Pharmaceutical company · Burlingame, California, United States · Nasdaq: ELVN
Enliven Therapeutics, Inc. is a pharmaceutical company headquartered in Burlingame, California, United States. Its earliest recorded incorporation is in 2016. Its shares trade on Nasdaq under the ticker ELVN. It has reported private securities offerings to the US SEC, most recently $90 million sold in a notice filed in 2024.
Enliven Therapeutics at a glance
What does Enliven Therapeutics do?
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $90 million sold (2024).
Frequently asked questions about Enliven Therapeutics
Where is Enliven Therapeutics headquartered?
Enliven Therapeutics, Inc. is headquartered in Burlingame, California, United States.
What does Enliven Therapeutics do?
Enliven Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Enliven Therapeutics a public company?
Yes. Enliven Therapeutics, Inc. trades on Nasdaq under the ticker ELVN.
When was Enliven Therapeutics founded?
The earliest incorporation on record for Enliven Therapeutics, Inc. is in 2016, according to public company registers.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.